Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-05-08 @ 5:54 PM
Study NCT ID:
NCT02070458
Status:
COMPLETED
Last Update Posted:
2018-12-13
First Post:
2014-02-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Case Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE7913
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |